immunization schedule

Summary

Summary: Schedule giving optimum times usually for primary and/or secondary immunization.

Top Publications

  1. doi Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data
    Andrew Clark
    Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK
    Lancet 373:1543-9. 2009
  2. ncbi Epidemiology of pertussis
    Tina Tan
    Feinberg School of Medicine, Division of Infectious Disease, Children s Memorial Hospital, 2300 Children s Plaza, Box 20, Chicago, IL 60614 3394, USA
    Pediatr Infect Dis J 24:S10-8. 2005
  3. ncbi A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents
    Eric E Mast
    Division of Viral Hepatitis, National Center for Infectious Diseases, USA
    MMWR Recomm Rep 54:1-31. 2005
  4. ncbi Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States
    Hayley A Gans
    Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305 5208, USA
    J Infect Dis 190:83-90. 2004
  5. ncbi Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children
    Arunee Sabchareon
    Vaccine Trial Center, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Pediatr Infect Dis J 23:99-109. 2004
  6. pmc Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom
    Ray Borrow
    PHLS Meningococcal Reference Unit, Withington Hospital, Manchester, United Kingdom
    Infect Immun 71:5549-55. 2003
  7. doi Hepatitis B and the need for a booster dose
    Elke Leuridan
    Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, Faculty of Medicine, University of Antwerp, Edegem, Belgium
    Clin Infect Dis 53:68-75. 2011
  8. ncbi A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults
    Eric E Mast
    Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention proposed, Atlanta, GA 30333, USA
    MMWR Recomm Rep 55:1-33; quiz CE1-4. 2006
  9. ncbi Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults
    Sorachai Nitayaphan
    Royal Thai Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    J Infect Dis 190:702-6. 2004
  10. ncbi Timeliness of childhood vaccinations in the United States: days undervaccinated and number of vaccines delayed
    Elizabeth T Luman
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 293:1204-11. 2005

Detail Information

Publications255 found, 100 shown here

  1. doi Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data
    Andrew Clark
    Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK
    Lancet 373:1543-9. 2009
    ..We estimated vaccination coverage at different ages, and delays in administration, in 45 low-income and middle-income countries...
  2. ncbi Epidemiology of pertussis
    Tina Tan
    Feinberg School of Medicine, Division of Infectious Disease, Children s Memorial Hospital, 2300 Children s Plaza, Box 20, Chicago, IL 60614 3394, USA
    Pediatr Infect Dis J 24:S10-8. 2005
    ..Understanding the link between these observations may lead to better informed global control strategies, especially those pertaining to immunization schedules and use of pertussis vaccine...
  3. ncbi A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents
    Eric E Mast
    Division of Viral Hepatitis, National Center for Infectious Diseases, USA
    MMWR Recomm Rep 54:1-31. 2005
    ..The second part of the ACIP statement, which will include updated recommendations and strategies to increase hepatitis B vaccination of adults, will be published separately...
  4. ncbi Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States
    Hayley A Gans
    Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305 5208, USA
    J Infect Dis 190:83-90. 2004
    ..Shifts in peak measles incidence to children <12 months old and the associated high mortality support the study of an early 2-dose measles vaccine regimen...
  5. ncbi Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children
    Arunee Sabchareon
    Vaccine Trial Center, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Pediatr Infect Dis J 23:99-109. 2004
    ..The safety and immunogenicity of tetravalent live-attenuated dengue vaccines after a three dose vaccination series were evaluated in Thai children...
  6. pmc Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom
    Ray Borrow
    PHLS Meningococcal Reference Unit, Withington Hospital, Manchester, United Kingdom
    Infect Immun 71:5549-55. 2003
    ..This study provides the first evidence that the number of doses of MCC-TT used in infant immunization schedules could be decreased...
  7. doi Hepatitis B and the need for a booster dose
    Elke Leuridan
    Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, Faculty of Medicine, University of Antwerp, Edegem, Belgium
    Clin Infect Dis 53:68-75. 2011
    ..However, a booster dose should be planned for immunocompromised patients, based on serological monitoring...
  8. ncbi A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults
    Eric E Mast
    Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention proposed, Atlanta, GA 30333, USA
    MMWR Recomm Rep 55:1-33; quiz CE1-4. 2006
    ....
  9. ncbi Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults
    Sorachai Nitayaphan
    Royal Thai Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    J Infect Dis 190:702-6. 2004
    ..This vaccine combination was well tolerated and was immunogenic, meeting milestones for advancement to phase 3 evaluation...
  10. ncbi Timeliness of childhood vaccinations in the United States: days undervaccinated and number of vaccines delayed
    Elizabeth T Luman
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 293:1204-11. 2005
    ..Only 18% of children in the United States receive all vaccinations at the recommended times or acceptably early...
  11. ncbi Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
    F T Cutts
    Medical Research Council Laboratories, Banjul, The Gambia
    Lancet 365:1139-46. 2005
    ..Pneumonia is estimated to cause 2 million deaths every year in children. Streptococcus pneumoniae is the most important cause of severe pneumonia. We aimed to assess the efficacy of a nine-valent pneumococcal conjugate vaccine in children...
  12. ncbi Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairs
    Peter Aaby
    Bandim Health Project, Apartado 861, Bissau, Guinea Bissau
    Int J Epidemiol 33:367-73. 2004
    ..As background information, we examined sex- and age-specific mortality patterns in the pre-vaccination era. Subjects In all, 626 female-male twin pairs identified between 1978 and 2000...
  13. ncbi Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: a model-based evaluation
    Philippe De Wals
    Faculty of Medicine, Laval University, and Quebec National Institute of Public Health, Canada
    Vaccine 24:3500-4. 2006
    ..Results showed that the efficacy of any immunization schedule was highly influenced by the rate at which immunity waned and that the benefit of a booster dose increased ..
  14. pmc Timeliness of childhood vaccinations in Kampala Uganda: a community-based cross-sectional study
    Juliet N Babirye
    School of Public Health, Makerere University College of Health Sciences, Kampala Uganda
    PLoS ONE 7:e35432. 2012
    ..In addition to examining timeliness of the recommended Expanded Programme for Immunisation (EPI) vaccines, this paper identifies predictors of untimely vaccination among children aged 10 to 23 months in Kampala...
  15. doi Alternative vaccination schedule preferences among parents of young children
    Amanda F Dempsey
    Child Health Evaluation and Research Unit, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI 48109 5456, USA
    Pediatrics 128:848-56. 2011
    ..We sought to describe national patterns of alternative vaccination schedule use and the potential "malleability" of parents' current vaccination schedule choices...
  16. ncbi Immunogenicity of a three-component acellular pertussis vaccine administered at birth
    Cesare Belloni
    Division of Neonatology and Neonatal Intensive Care, IRCCS Policlinico San Matteo Pavia, Italy
    Pediatrics 111:1042-5. 2003
    ..Furthermore, we investigated the influence of maternal antibodies on aP vaccine response...
  17. ncbi Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany
    Dorothee M Kieninger
    Arztin für Kinder und Jugendmedizin, Zentrum für Kinder und Jugendmedizin der Universitätsmedizin der Johannes Gutenberg Universität Mainz KOR, Mainz, Germany
    Vaccine 28:4192-203. 2010
    ..Vaccines were comparable with regard to safety. PCV13 should be as effective as PCV7 in preventing pneumococcal disease caused by the common serotypes and may provide protection against the additional serotypes...
  18. ncbi Haemophilus influenzae type b conjugate vaccines: considerations for vaccination schedules and implications for developing countries
    Sean P Fitzwater
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Hum Vaccin 6:810-8. 2010
    ..Here, we present a synthesis of data supporting various Hib vaccine schedules, with a focus on the implications for developing countries...
  19. pmc Vaccination coverage and timeliness in three South African areas: a prospective study
    Lars T Fadnes
    Centre for International Health, University of Bergen, Norway
    BMC Public Health 11:404. 2011
    ..Timely vaccination is important to induce adequate protective immunity. We measured vaccination timeliness and vaccination coverage in three geographical areas in South Africa...
  20. pmc Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy
    F M Russell
    Centre for International Child Health, Department of Paediatrics, University of Melbourne, Royal Children s Hospital, Melbourne, Australia
    Vaccine 28:3086-94. 2010
    ..By 17 months the PPV-23 group still had significantly higher GMC (each p<0.001) for all serotypes. The PPV-23 was well tolerated and induced excellent responses for all serotypes which were greatest in the single PCV-7 group...
  21. doi Is vaccination coverage a good indicator of age-appropriate vaccination? A prospective study from Uganda
    Lars T Fadnes
    Centre for International Health, University of Bergen, 5018 Bergen, Norway
    Vaccine 29:3564-70. 2011
    ..Timely vaccination is important to protect children from common infectious diseases. We assessed vaccination timeliness and vaccination coverage as well as coverage of vitamin A supplementation in a Ugandan setting...
  22. doi The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization schedule
    Martin O Ota
    Medical Research Council Laboratories, Banjul, Gambia
    Vaccine 29:2999-3007. 2011
    ....
  23. doi Serogroup C Neisseria meningitidis invasive infection: analysis of the possible vaccination strategies for a mass campaign
    Elena Chiappini
    Department of Sciences for Woman and Child s Health, University of Florence, Viale Pieraccini, Florence, Italy
    Acta Paediatr 99:1609-14. 2010
    ..In the absence of randomized controlled trials that support a specific schedule, each country has adopted different vaccination programmes. Hereby, we analyse positive and negative aspects of the different vaccination strategies...
  24. ncbi Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
    Sander Van Assen
    Department of Internal Medicine, Division of Infectious Diseases, University Medical Center Groningen, Groningen, The Netherlands
    Arthritis Rheum 62:75-81. 2010
    ..We also undertook to assess the safety of influenza vaccination and the effects of previous influenza vaccination...
  25. ncbi General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP)
    William L Atkinson
    Immunization Services Division, National Center for Infectious Diseases, USA
    MMWR Recomm Rep 51:1-35. 2002
    ..This report, ACIP recommendations for each vaccine, and other information regarding immunization can be accessed at CDCs National Immunization Program website at http.//www.cdc.gov/nip (accessed October 11, 2001)...
  26. pmc Effectiveness of individually tailored calendars in promoting childhood immunization in urban public health centers
    Matthew W Kreuter
    Health Communication Research Laboratory, Division of Behavioral Science and Health Education, Department of Community Health, School of Public Health, Saint Louis University, St Louis, MO 63104, USA
    Am J Public Health 94:122-7. 2004
    ..We examined the effectiveness of tailored calendars in increasing childhood immunization rates...
  27. ncbi Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial
    Terry Nolan
    Vaccine and Immunization Research Group, School of Population Health, University of Melbourne, and Murdoch Children s Research Institute, Victoria, Australia
    JAMA 303:37-46. 2010
    ..In the ongoing influenza pandemic, a safe and effective vaccine against 2009 influenza A(H1N1) is needed for infants and children...
  28. ncbi Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial
    Roly D Gosling
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
    Lancet 374:1521-32. 2009
    ..However, rising resistance to this combination is a concern. We investigated a shortacting and longacting antimalarial drug as alternative regimens for IPTi...
  29. ncbi Addressing immunization barriers, benefits, and risks
    Sanford R Kimmel
    Department of Family Medicine, University of Toledo College of Medicine, Toledo, OH, USA
    J Fam Pract 56:S61-9. 2007
    ..They must also clearly communicate vaccine benefits and risks while understanding those factors that affect an individual's acceptance and perception of those benefits and risks...
  30. ncbi Benefits of routine immunizations on childhood survival in Tari, Southern Highlands Province, Papua New Guinea
    Deborah Lehmann
    Papua New Guinea Institute of Medical Research, Goroka and Tari, Papua New Guinea
    Int J Epidemiol 34:138-48. 2005
    ..This study aimed to determine the effects of diphtheria-tetanus-whole-cell-pertussis (DTP), BCG, hepatitis B, and measles vaccines on mortality in the highlands of Papua New Guinea (PNG)...
  31. doi Benefits of early hepatitis B immunization programs for newborns and infants
    Koen Van Herck
    WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Vaccine, and Infectious Disease Institute, University of Antwerp, Belgium
    Pediatr Infect Dis J 27:861-9. 2008
    ....
  32. doi Immunisation coverage in Australian Indigenous children: Time to move the goal posts
    Kerry Ann O'Grady
    School of Population Health and Department of Paediatrics, University of Melbourne, Victoria, Australia
    Vaccine 27:307-12. 2009
    ..5% and 81.2% at 13 and 18 months of age, respectively. Immunisation performance benchmarks must focus on improving the timeliness in these children in the first year of life...
  33. pmc Immunization status of children admitted to a tertiary-care hospital of north India: reasons for partial immunization or non-immunization
    Devendra Kumar
    Department of Pediatrics, University College of Medical Science and Guru Teg Bahadur Hospital, Delhi 110 095, India
    J Health Popul Nutr 28:300-4. 2010
    ..The immunization status needs to be improved by education, increasing awareness, and counselling of parents and caregivers regarding immunizations and associated misconceptions as observed in the study...
  34. ncbi Systematic review of the effects of pertussis vaccines in children
    Tom Jefferson
    Health Reviews Ltd, Via Adige 28a, 00061 Anguillara Sabazia, Rome, Italy
    Vaccine 21:2003-14. 2003
    ..To assess the efficacy and safety of whole-cell and acellular pertussis vaccines administered to children singly or within diphtheria, tetanus and pertussis (DTP) vaccines...
  35. pmc Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies
    L Coudeville
    Sanofi Pasteur, Lyon, France
    Epidemiol Infect 136:604-20. 2008
    ..The model also predicts that the optimal age for this booster dose is 40 years. These results support the 2006 American Academy of Immunization Practices' recommendations for adolescent and adult vaccination against pertussis...
  36. doi Scheduling of measles vaccination in low-income countries: projections of a dynamic model
    C T Bauch
    Department of Mathematics and Statistics, University of Guelph, Guelph, ON N1G 2W1, Canada
    Vaccine 27:4090-8. 2009
    ..If RI remains stagnant, India and Nigeria should hold SIAs every 2 years, and the other countries every 4-6 years...
  37. ncbi Infant pertussis: who was the source?
    Kristine M Bisgard
    Bacterial Vaccine Preventable Diseases Branch, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 23:985-9. 2004
    ..In the United States in the 1990s, the incidence of reported pertussis in adults, adolescents and infants increased; infants younger than 1 year of age had the highest reported incidence...
  38. ncbi Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response
    María Victoria Lavigne
    Instituto de Estudios de la Inmunidad Humoral CONICET UBA, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires, Junín 956 Piso 4, 1113 Buenos Aires, Argentina
    Microbes Infect 6:481-4. 2004
    ..is not necessary for protection against tetanus and therefore should be avoided, an alternative DTP immunization schedule with minimal Pw exposure was assessed in order to obtain a Th2 tetanus response and a Th1 pertussis ..
  39. ncbi Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B
    Gillian M Keating
    Adis International Limited, Auckland, New Zealand
    Drugs 63:1021-51. 2003
    ..In addition, it appears that Hep-B(Eng) confers immunity for at least 10 years. Hep-B(Eng) has an important role in mass vaccination campaigns against hepatitis B, as well as in groups considered at high risk of acquiring hepatitis B...
  40. ncbi Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein
    Suzanne L Epstein
    Laboratory of Immunology and Developmental Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Bethesda, MD 20852, USA
    Vaccine 23:5404-10. 2005
    ..Thus, gene-based vaccination with NP may contribute to protective immunity against diverse influenza viruses through its ability to stimulate cellular immunity...
  41. doi Early Impact of the US Tdap vaccination program on pertussis trends
    Tami H Skoff
    Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mail Stop C 25, Atlanta, GA 30333, USA
    Arch Pediatr Adolesc Med 166:344-9. 2012
    ..To evaluate the impact of the adolescent Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine) vaccination program on pertussis trends in the United States...
  42. pmc Infant mortality rates regressed against number of vaccine doses routinely given: is there a biochemical or synergistic toxicity?
    Neil Z Miller
    Think Twice Global Vaccine Institute, USA corrected
    Hum Exp Toxicol 30:1420-8. 2011
    ..The US childhood immunization schedule specifies 26 vaccine doses for infants aged less than 1 year--the most in the world--yet 33 nations have ..
  43. ncbi Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controll
    Menno R van den Bergh
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, University Medical Center Utrecht, The Netherlands
    Pediatr Infect Dis J 30:e170-8. 2011
    ..Recent reviews have highlighted the unpredictability of immunologic interference when multivalent conjugated vaccines are coadministered with other pediatric vaccines...
  44. doi Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up
    L Roznovsky
    Department of Infectious Diseases, University Hospital Ostrava, Tr 17 listopadu 1790, 708 52 Ostrava, Czech Republic
    Infection 38:395-400. 2010
    ..However, whether this protection against carriage of hepatitis B virus is maintained into early adulthood is as yet unknown...
  45. ncbi Protecting infants against measles in England and Wales: a review
    G Manikkavasagan
    HPA Centre for Infections, London NW9 5EQ, UK
    Arch Dis Child 94:681-5. 2009
    ..To establish the most appropriate age ranges for the use of human normal immunoglobulin and MMR vaccine as postexposure prophylaxis...
  46. ncbi Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina
    G Fabricius
    Instituto de Investigaciones Fisicoquimicas Teoricas y Aplicadas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata, Argentina
    Epidemiol Infect 141:718-34. 2013
    ..An effort to improve the coverage of the first dose would have a much greater impact on infants. These results hold in the 18 scenarios considered, which demonstrates the robustness of these conclusions...
  47. pmc Effectiveness of measles vaccination and vitamin A treatment
    Christopher R Sudfeld
    Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, MD 21205, USA
    Int J Epidemiol 39:i48-55. 2010
    ....
  48. ncbi Evaluation of non-specific effects of infant immunizations on early infant mortality in a southern Indian population
    Lawrence H Moulton
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Trop Med Int Health 10:947-55. 2005
    ..The aim of this study was to assess the relationship between receipt of routine childhood immunizations and infant mortality before 6 months of age...
  49. pmc Accelerating control of pertussis in England and Wales
    Helen Campbell
    Health Protection Agency, London, UK
    Emerg Infect Dis 18:38-47. 2012
    ..e., <3 months of age), teenagers, and adults. Future vaccine program changes may be beneficial, but additional detail is required to inform such decisions...
  50. ncbi The impact of computer-generated messages on childhood immunization coverage
    E F Dini
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Am J Prev Med 18:132-9. 2000
    ..This study assesses the sustained impact of computer-generated messages on immunization coverage during the first two years of life...
  51. ncbi Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children
    M E Pichichero
    Department of Microbiology, University of Rochester School of Medicine, Rochester, New York, USA
    Pediatrics 105:e11. 2000
    ....
  52. ncbi Vaccination schedules to raise antibody concentrations against epsilon-toxin of Clostridium perfringens in ewes and their triplet lambs
    C de la Rosa
    Department of Animal Science, Cornell University, Ithaca, NY 14853 4801, USA
    J Anim Sci 75:2328-34. 1997
    ..Because concentrations of .2 IU/mL may be protective, these results indicate that vaccination of ewes before lambing imparts passive protection in lambs to 12 wk of age, whereas vaccination of young lambs provides no added protection...
  53. ncbi Effectiveness and net cost of reminder/recall for adolescent immunizations
    Christina A Suh
    Children s Outcomes Research Program, Children s Hospital Colorado, Aurora, Colorado 80045, USA
    Pediatrics 129:e1437-45. 2012
    ..To assess the effectiveness of reminder/recall (R/R) for immunizing adolescents in private pediatric practices and to describe the associated costs and revenues...
  54. doi Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands
    Tjalke A Westra
    Department of Pharmacy, University of Groningen, The Netherlands
    Clin Ther 32:1479-95. 2010
    ..Because pertussis is most severe in unimmunized infants and infants who have only received some of the recommended doses, new pertussis immunization strategies should be considered to protect this vulnerable population...
  55. ncbi Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120
    Farley Cleghorn
    Center for HIV AIDS, Constella Futures, Washington, DC, USA
    J Acquir Immune Defic Syndr 46:222-30. 2007
    ..vCP1452 was administered alone or with a heterologous boost of MN rgp120 glycoprotein. The trial was pivotal in deciding whether these vaccines advanced to phase 3 efficacy trials...
  56. ncbi DTP with or after measles vaccination is associated with increased in-hospital mortality in Guinea-Bissau
    Peter Aaby
    Projecto de Saude de Bandim, Apartado 861, Bissau, Guinea Bissau
    Vaccine 25:1265-9. 2007
    ..The sequence is not always respected. We examined in-hospital mortality of children having received DTP with or after measles vaccine...
  57. doi Modifying the antigen-immunization schedule improves the variety of monoclonal antibodies obtained from immune-phage antibody libraries against HIV-1 Nef and Vif
    Mai Yoshikawa
    Department of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan
    J Biosci Bioeng 111:597-9. 2011
    ..Here we show that the immunization schedule affects the immune phage antibody library properties. We subcutaneously (s.c...
  58. doi Hepatitis B Vaccine in national immunization schedule: a preventive step in India
    RAMESH VERMA
    Department of Community Medicine, Pt B D Sharma PGIMS, Rohtak Haryana, India
    Hum Vaccin 7:1387-8. 2011
    ..The current immunization schedule for hepatitis B vaccine includes a dose given as early as possible after birth, preferably within 24 hours ..
  59. ncbi Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccination
    Veronica Kolos
    University of Sydney, Australia
    Vaccine 25:588-90. 2007
    ..These data suggest that residence in a remote area, as a proxy for poorer living conditions for indigenous people, and delayed vaccination, both contribute to higher pertussis hospitalization rates in indigenous infants...
  60. ncbi The relation of parent and provider characteristics to vaccination status of children in private practices and managed care organizations in Maryland
    N Hughart
    Department of Maternal and Child Health, Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD 21205, USA
    Med Care 37:44-55. 1999
    ..This study sought to identify provider practices and policies in private pediatric settings that relate to vaccination status, controlling for the characteristics of the children served...
  61. ncbi Minimum time interval adjustment for 4-3-1 immunization rates among two-year-old children
    R P Steiner
    Department of Family and Community Medicine, University of Louisville, Kentucky 40292, USA
    Am J Prev Med 16:189-94. 1999
    ....
  62. ncbi Predictors of age-appropriate receipt of DTaP dose 4
    Tara W Strine
    Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Am J Prev Med 25:45-9. 2003
    In the United States, the national childhood immunization schedule calls for children to receive four doses of DTaP (diphtheria and tetanus toxoids and acellular pertussis) vaccine administered at 2, 4, 6, and 15 to 18 months...
  63. ncbi Compliance with national immunization guidelines for children younger than 2 years, 1996-1999
    Loren K Mell
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Pediatrics 115:461-7. 2005
    ..To evaluate compliance with national immunization guidelines among a large cohort of children cared for at health maintenance organizations (HMOs) and to examine effects on immunization status...
  64. doi Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua
    Manish Patel
    Viral Gastroenteritis Section, MS A47, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, Atlanta, GA 30333, USA
    JAMA 301:2243-51. 2009
    ..Nicaragua introduced RV5 in 2006, providing the first opportunity to assess the association between vaccination and rotavirus disease in a developing country...
  65. ncbi Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule
    M Magdalena Gherardi
    Department of Molecular and Cellular Biology, Centro Nacional de Biotecnologia, Consejo Superior de Investigaciones Cientificas, Campus Universidad Autonoma, Madrid, Spain
    J Immunol 172:6209-20. 2004
    ..Our findings are of relevance in the area of vaccine development and support the optimization of protocols of immunization based on MVA as vaccine vectors to induce mucosal immune responses against HIV...
  66. ncbi Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
    J J Treanor
    Infectious Diseases Unit, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Vaccine 19:1732-7. 2001
    ..These results suggest that baculovirus-expressed H5 HA can induce functional antibody in individuals who have not had prior exposure to H5 viruses, but that further studies to improve the immunogenicity of the vaccine are needed...
  67. doi Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States
    Ismael R Ortega-Sanchez
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 46:1-13. 2008
    ..The objective of our study was to analyze the cost-effectiveness of a catch-up vaccination campaign with quadrivalent meningococcal conjugate vaccine for children and adolescents aged 11-17 years...
  68. doi When and why children fall behind with vaccinations: missed visits and missed opportunities at milestone ages
    Elizabeth T Luman
    National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia 30333, USA
    Am J Prev Med 36:105-11. 2009
    ....
  69. ncbi A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth
    Salvacion Gatchalian
    Research Institute for Tropical Medicine, Filinvest Corporate Centre, Alabang, Muntinlupa City, Manila, Philippines
    Hum Vaccin 1:198-203. 2005
    ..A birth dose of HBV is important to maximize protection against hepatitis B in endemic regions where the EPI schedule is in place...
  70. ncbi General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Andrew T Kroger
    Immunization Services Division, National Center for Immunization and Respiratory Diseases proposed, CDC, Atlanta, GA 30333, USA
    MMWR Recomm Rep 55:1-48. 2006
    ..cdc.gov/nip...
  71. ncbi Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses
    Arunee Sabchareon
    Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Am J Trop Med Hyg 66:264-72. 2002
    ..All subjects seroconverted to serotype 3 after one dose. Serotype 4 elicited the lowest primary response but the highest increase in seroconversion after the second dose...
  72. ncbi Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience
    S Salmaso
    Laboratories of Epidemiology and Biostatistics and Bacteriology and Medical Mycology, Istituto Superiore di Sanita, Rome, Italy
    Pediatrics 108:E81. 2001
    ..Therefore, the objective of this study was to estimate the persistence of protection from 3 to 6 years of age of the 2 3-component DTaP vaccines administered as primary immunization in infancy...
  73. ncbi Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis
    Fangjun Zhou
    National Immunization Program, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, Georgia 30333, USA
    Pediatrics 110:653-61. 2002
    ..To evaluate the economic impact of universal Haemophilus influenzae type b (Hib) vaccination starting at 2 months of age...
  74. ncbi Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age
    Lennart Gustafsson
    Swedish Institute for Infectious Disease Control, SE 171 82 Solna, Sweden
    Pediatrics 118:978-84. 2006
    ..The purpose of this work was to evaluate the long-term effectiveness of vaccination with acellular pertussis vaccines at 3, 5, and 12 months of age...
  75. ncbi Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth
    Kenneth M Petersen
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
    Pediatr Infect Dis J 23:650-5. 2004
    ..The duration of protection after hepatitis B vaccination of infants is unknown...
  76. pmc Timeliness and completion rate of immunization among Nigerian children attending a clinic-based immunization service
    Ayebo E Sadoh
    Institute of Child Health, University of Benin, PMB 1154, Benin City, Edo State, Nigeria
    J Health Popul Nutr 27:391-5. 2009
    ..Only 227 (44.3%) children were fully immunized. Health education and mass mobilization of the community and health workers are recommended to improve the uptake of vaccines and to encourage timely receipt of vaccines...
  77. pmc Short term evaluation of a rural immunization program in Nigeria
    O O Odusanya
    Department of Community Health and Primary Care, Lagos State University College of Medicine, Ikeja, Nigeria
    J Natl Med Assoc 95:175-9. 2003
    ....
  78. ncbi Response to hepatitis B vaccine in preterm infants: four-dose schedule
    A Ballesteros-Trujillo
    Department of Neonatology, , Instituto Mexicano del Seguro Social, , Gto,
    Am J Perinatol 18:379-85. 2001
    ..Our schedule seems to be useful for PI infants and probably is no longer necessary to delay the vaccination, although this should be confirmed by further studies...
  79. ncbi Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial
    Leon Heron
    National Center for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Childrens Hospital, Westmead, Australia
    Vaccine 25:2817-22. 2007
    ..Both regimens were shown to be safe and well tolerated. Two doses of Engerix-B (20 microg HBsAg) could be considered as an alternative to standard three-dose Engerix-B (10 microg HBsAg) immunisation for adolescents aged 11-15 years...
  80. ncbi Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content
    Khin Hla Hla
    Pediatric Unit No 2, Military Hospital, Dagon Township, Yangon, Myanmar
    Pediatr Infect Dis J 25:706-12. 2006
    ..5 microg of polyribosylribitol phosphate (PRP) conjugated to tetanus toxoid (trials Hib-052/064)...
  81. ncbi Immunogenicity and safety of combined diphtheria tetanus whole cell pertussis hepatitis B/ Haemophilus influenzae type b vaccine in Indian infants
    S B Bavdekar
    Seth G S Medial College and K E M Hospital, Mumbai, India
    Indian Pediatr 44:505-10. 2007
    ..To evaluate the immunogenicity of the Hepatitis B and Haemophilus influenzae type b components and the overall safety and reactogenicity of the DTPw-HBV/Hib vaccine when given as primary vaccination to Indian infants...
  82. ncbi The use of combination vaccines has improved timeliness of vaccination in children
    Helen Kalies
    Department of Pediatric Epidemiology, Institute for Social Pediatrics and Adolescent Medicine of Ludwig Maximilians University, Munich, Germany
    Pediatr Infect Dis J 25:507-12. 2006
    ..We examined whether the use of combination vaccines has improved the timing of these vaccinations...
  83. ncbi Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain
    Paul M Mendelman
    MedImmune Vaccines, Mountain View, CA, USA
    Pediatr Infect Dis J 23:1053-5. 2004
    ..Results indicated that the live vaccine induced higher antibody responses than the inactivated vaccine against the A/Panama and A/Fujian-like viruses...
  84. ncbi Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines
    Robin E Huebner
    Respiratory and Meningeal Pathogens Research Unit of the Medical Research Council, National Health Laboratory Service and the University of the Witwatersrand, Johannesburg, South Africa
    Vaccine 23:802-6. 2004
    ..Our data suggest that doses of these vaccines of > or =1.25 microg may be sufficient to stimulate an immune response that offers both short and longer term protection from invasive Hib disease...
  85. ncbi A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America
    Miguel Tregnaghi
    Centro de Desarrollo de Proyectos Avanzados, Cordoba, Argentina
    Rev Panam Salud Publica 19:179-88. 2006
    ....
  86. ncbi Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country
    Bernard Duval
    Institut National de Sante Publique du Quebec, Quebec, Canada
    Pediatr Infect Dis J 24:213-8. 2005
    ..The long term effect of the booster dose in teenagers is unknown. We evaluated the immunogenicity of 2 pediatric hepatitis vaccines after primary vaccination and after a booster dose...
  87. ncbi Sex differential effects of routine immunizations and childhood survival in rural Malawi
    Peter Aaby
    Danish Epidemiology Science Centre, Statens Serum Institut, Copenhagen, Denmark
    Pediatr Infect Dis J 25:721-7. 2006
    ..Recent studies from West Africa suggest that routine vaccinations may have sex differential nontargeted effects. To answer whether these patterns are found elsewhere, we reanalyzed data about vaccinations and mortality in a Malawian cohort...
  88. ncbi Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine
    Félix Omeñaca
    Department of Neonatology, La Paz Hospital, Madrid, Spain
    Pediatrics 119:e179-85. 2007
    ....
  89. ncbi Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Umesh D Parashar
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Rd, NE MS A 34, Atlanta, GA 30333, USA
    MMWR Recomm Rep 55:1-13. 2006
    ..Rotavirus vaccine can be co-administered with other childhood vaccines. Rotavirus vaccine is contraindicated for infants with a serious allergic reaction to any vaccine component or to a previous dose of vaccine...
  90. ncbi Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001
    Fangjun Zhou
    National Immunization Program, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, GA 30333, USA
    Arch Pediatr Adolesc Med 159:1136-44. 2005
    To evaluate the economic impact of the routine US childhood immunization schedule: diphtheria and tetanus toxoids and acellular pertussis; tetanus and diphtheria toxoids; Haemophilus influenzae type b conjugate; inactivated poliovirus; ..
  91. ncbi Timeliness of childhood immunisation in Australia
    Brynley P Hull
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children s Hospital at Westmead and the University of Sydney, NSW, Australia
    Vaccine 24:4403-8. 2006
    ....
  92. pmc Assessing immunization data quality from routine reports in Mozambique
    João C Mavimbe
    Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique
    BMC Public Health 5:108. 2005
    ..The present article, discusses the practices on record keeping, reporting and the support mechanism to ensure data quality in Mozambique...
  93. pmc Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets
    Amorsolo L Suguitan
    Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
    PLoS Med 3:e360. 2006
    ....
  94. ncbi Immunization coverage and its determinants in children aged 12-23 months in Gansu, China
    Fu Qiang Cui
    Chinese Center for Disease Control and Prevention, P O Box 100050, Beijing, China
    Vaccine 25:664-71. 2007
    ..Improved immunization coverage could be achieved by improving access and delivery to poor and remote areas and by awarding incentives to providers at primary care level...
  95. ncbi Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria
    Elissa M Malkin
    Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5640 Fishers Lane, Twinbrook 1, Room 1123, Rockville, MD 20852, USA
    Vaccine 23:3131-8. 2005
    ..Pvs25H generates transmission blocking immunity in humans against P. vivax demonstrating the potential of this antigen as a component of a transmission blocking vaccine...
  96. ncbi Immunogenicity of hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life
    Márcia Soares Freitas da Motta
    Department of Pediatrics, School of Medicine of Ribeirao Preto, University of Sao Paulo, Av dos Bandeirantes no 3900, Ribeirao Preto, Sao Paulo, Brazil
    Vaccine 20:1557-62. 2002
    ..Currently accepted recommendations for post exposure perinatal prophylaxis may be inadequate to protect preterm infants...
  97. pmc Hepatitis B vaccination in children with juvenile idiopathic arthritis
    O Kasapcopur
    Department of Pediatrics, Cerrahpaa Medical Faculty, Istanbul University, Istanbul, Turkey
    Ann Rheum Dis 63:1128-30. 2004
    ..To evaluate the responsiveness of children with juvenile idiopathic arthritis (JIA) to hepatitis B vaccination and to determine the most useful vaccination schedule...
  98. ncbi Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population
    Iain Stephenson
    Infectious Diseases Unit, Leicester Royal Infirmary, LE1 5WW, Leicester, UK
    Vaccine 21:1687-93. 2003
    ..001). MF59 significantly increased GMTs of antibody when compared to non-adjuvanted vaccine (P<0.001)...
  99. pmc Delayed immunisation and risk of pertussis in infants: unmatched case-control study
    Cameron C Grant
    Department of Paediatrics, Faculty of Medicine and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
    BMJ 326:852-3. 2003
  100. ncbi Hepatitis B vaccination: long-term follow-up of the immune response of preterm infants and comparison of two vaccination protocols
    N Linder
    Dept of Neonatology, Schneider Children s Medical Center of Israel, Petah Tiqva
    Infection 30:136-9. 2002
    ..Two three-dose protocols were compared: vaccination beginning within 24 h of birth to initial vaccination delayed until a weight of 2,000 g was reached...
  101. ncbi The need for surveillance of delay in age-appropriate immunization
    Kevin J Dombkowski
    Child Health Evaluation and Research Unit, Division of General Pediatrics, University of Michigan, Ann Arbor 48109 0456, USA
    Am J Prev Med 23:36-42. 2002
    ..Our study was conducted in 2000-2001 using the most current National Health Interview Survey (NHIS) public use files available...

Research Grants98

  1. The impact of the pneumococcal conjugate vaccine on pneumonia hospitalizations
    CARLOS GRIJALVA; Fiscal Year: 2007
    ..S. infant immunization schedule. Post-licensure surveillance has shown dramatic reductions in rates of invasive disease in vaccinated ..
  2. Enhanced Academic Detailing to Increase Immunization Recall Rate
    JOSEPH GARY WHEELER; Fiscal Year: 2010
    ..abstract_text> ..
  3. Influenza Immunization of Children in India
    Wayne M Sullender; Fiscal Year: 2011
    ..The temporal circulation of influenza in India suggests the current fall immunization schedule may not be optimal...
  4. BioThrax Schedule Optimization for Post-Exposure Prophylaxis of Anthrax
    Robert Hopkins; Fiscal Year: 2006
    ..This phase 3b clinical trial, Safety, Immunogenicity, and Immunization Schedule Study of Post-Exposure Prophylaxis for BioThrax(r) in a Population of Healthy Adults, will evaluate the ..
  5. MICROSPHERES TO ENHANCE VACCINE IMMUNOGENICITY
    John Eldridge; Fiscal Year: 1992
    ..in a series of DL-PLGs designed to release vaccine pulses which mimic the current 2, 4, 6 and 15-19 month immunization schedule after a single injection...
  6. Novel Engineering of a P. falciparum Merozoite Surface Protein 1 Malaria Vaccine
    GEORGE S HUI; Fiscal Year: 2010
    ..regimens to efficiently induce protective antibodies under the more favorable logistics of a reduced immunization schedule and the use of readily acceptable adjuvants...
  7. Novel Engineering of a P. falciparum Merozoite Surface Protein 1 Malaria Vaccine
    George Hui; Fiscal Year: 2009
    ..regimens to efficiently induce protective antibodies under the more favorable logistics of a reduced immunization schedule and the use of readily acceptable adjuvants...
  8. Understanding & Estimating Costs of Vaccine Development,Production and Pricing
    Matthew Davis; Fiscal Year: 2006
    ..However, the rapidly expanding immunization schedule and increasingly expensive vaccines threaten the fiscal stability of public vaccine financing at federal ..
  9. Understanding & Estimating Costs of Vaccine Development,Production and Pricing
    Matthew Davis; Fiscal Year: 2007
    ..However, the rapidly expanding immunization schedule and increasingly expensive vaccines threaten the fiscal stability of public vaccine financing at federal ..
  10. A Randomized Trial of Vaccine Adherence in Young IDU
    Paula Lum; Fiscal Year: 2006
    ..none) in enhancing adherence to a multiple dose immunization schedule. We have three secondary objectives...
  11. A Randomized Trial of Vaccine Adherence in Young IDU
    Paula Lum; Fiscal Year: 2004
    ..none) in enhancing adherence to a multiple dose immunization schedule. We have three secondary objectives...
  12. A Randomized Trial of Vaccine Adherence in Young IDU
    Paula Lum; Fiscal Year: 2005
    ..none) in enhancing adherence to a multiple dose immunization schedule. We have three secondary objectives...
  13. A Randomized Trial of Vaccine Adherence in Young IDU
    Paula Lum; Fiscal Year: 2003
    ..none) in enhancing adherence to a multiple dose immunization schedule. We have three secondary objectives...
  14. A Randomized Trial of Vaccine Adherence in Young IDU
    Paula Lum; Fiscal Year: 2005
    ..none) in enhancing adherence to a multiple dose immunization schedule. We have three secondary objectives...
  15. Lactoferrin as an Adjuvant for Cellular Immunity
    Jeffrey Actor; Fiscal Year: 2009
    ..Areas that require further investigation concern (i) optimization of the immunization schedule for use of the adjuvant;and (ii) whether the production protocol developed for the initial expression of ..
  16. Lactoferrin as an Adjuvant for Cellular Immunity
    Jeffrey K Actor; Fiscal Year: 2010
    ..Areas that require further investigation concern (i) optimization of the immunization schedule for use of the adjuvant;and (ii) whether the production protocol developed for the initial expression of ..
  17. IMMUNOLOGICAL MECHANISM OF ANAPHYLAXIS
    Zoltan Ovary; Fiscal Year: 1980
    ..Another, more sophisticated adoptive transfer immunization schedule had to be devised in order to examine the mechanism of action of the unprimed T cells...
  18. NEW VACCINE SURVEILLANCE NETWORK
    NATASHA BASSAM HALASA; Fiscal Year: 2011
    ..g. pneumococcal conjugate and rotavirus vaccines) to the current childhood immunization schedule represents a great opportunity for improvement of the public health...
  19. FERTILITY TRIAL OF NATIVE SPERM & SEMINAL PROTEINS IN CYNOMOLGUS MACAQUES
    CHERRIE BROWN; Fiscal Year: 1999
    ..Following the immunization schedule, a series of timed matings will be scheduled over 4 consecutive menstrual cycles...
  20. Clinical Research and Mentoring in Epidemiology of Bacterial Diseases
    Lee Harrison; Fiscal Year: 2009
    ..the potential to improve clinical care of bacterial meningitis patients in Brazil and provide policy makers with information for informed decisions about incorporation of new conjugate vaccines into the Brazilian immunization schedule.
  21. Clinical Research and Mentoring in Epidemiology of Bacterial Diseases
    Lee H Harrison; Fiscal Year: 2010
    ..the potential to improve clinical care of bacterial meningitis patients in Brazil and provide policy makers with information for informed decisions about incorporation of new conjugate vaccines into the Brazilian immunization schedule.
  22. UTILIZATION OF IMMUNIZATION SVCS: PSYCHOSOCIAL APPROACH
    Hoda Atta; Fiscal Year: 1993
    ..Psychosocial factors to be examined in this subset include: knowledge about immunization schedule, vaccine availability, vaccine preventable disease, and health services that provide the vaccine; ..
  23. Generation of antibodies by genetic immunization
    Hans Herweijer; Fiscal Year: 2002
    ..studies, we will further optimize genetic immunization methods by including cytokine genes, refining the immunization schedule, and testing different expression vectors and mouse strains...
  24. Production of neutralizing mAbs from HIV vaccinees
    Shixia Wang; Fiscal Year: 2012
    ..of Env-specific mAbs from additional vaccinees including PBMCs collected at different time points in the immunization schedule. PUBLIC HEALTH RELEVANCE: We propose to use existing blood cells collected from human volunteers who ..
  25. Production of neutralizing mAbs from HIV vaccinees
    Shixia Wang; Fiscal Year: 2010
    ..of Env-specific mAbs from additional vaccinees including PBMCs collected at different time points in the immunization schedule. PUBLIC HEALTH RELEVANCE: We propose to use existing blood cells collected from human volunteers who ..
  26. IMMUNOTHERAPY OF MELANOMA WITH ANTIIDIOTYPIC ANTIBODIES
    Soldano Ferrone; Fiscal Year: 1999
    ..The information resulting from studies in animal model systems will be utilized to design the immunization schedule with the most effective adjuvant and combination of anti-id mAb in patients with advanced melanoma in a ..
  27. Therapeutic Immunization in Humans
    Julianna Lisziewicz; Fiscal Year: 2003
    ..The study is aimed to determine whether a one immunization schedule could replace and improve the two consecutive immunization schedule originally administered in the monkey ..
  28. IDIOTYPIC NETWORK IN MELANOMA
    Soldano Ferrone; Fiscal Year: 1992
    ..analyze the immunogenicity of humanized MoAb MK2-23, since this information will be useful to optimize the immunization schedule in patients with melanoma...
  29. ACTG 230--HIV 1 ENVELOPE ANTIGEN IN INFANT OF HIV MOTHER
    Deborah Persaud; Fiscal Year: 2000
    ..An accelerated immunization schedule ( birth, 2 weeks, 2 and 5 months) with the lowest dose of the SF-2 vaccine produced responses in all 11 ..
  30. DETERMINING/UNDERSTANDING BARRIERS TO ADULT IMMUNIZATION
    Richard Zimmerman; Fiscal Year: 2001
    ..This project will furnish relevant, up-to-date to enhance policy planning, practice management and medical education. ..
  31. DETERMINING/UNDERSTANDING BARRIERS TO ADULT IMMUNIZATION
    Richard Zimmerman; Fiscal Year: 1999
    ..This project will furnish relevant, up-to-date to enhance policy planning, practice management and medical education. ..
  32. DETERMINING/UNDERSTANDING BARRIERS TO ADULT IMMUNIZATION
    Richard Zimmerman; Fiscal Year: 2000
    ..This project will furnish relevant, up-to-date to enhance policy planning, practice management and medical education. ..
  33. DETERMINING/UNDERSTANDING BARRIERS TO ADULT IMMUNIZATION
    Richard Zimmerman; Fiscal Year: 1999
    ..This project will furnish relevant, up-to-date to enhance policy planning, practice management and medical education. ..
  34. Predictors of Cancer Screening in Diverse Practices
    Richard Zimmerman; Fiscal Year: 2004
    ..Without understanding the barriers to prevention from multiple vantage points, the rates of preventive services are unlikely to reach 2010 goals and needless cancer deaths will occur. ..
  35. DETERMINING/UNDERSTANDING BARRIERS TO ADULT IMMUNIZATION
    Richard Zimmerman; Fiscal Year: 2001
    ..This project will furnish relevant, up-to-date to enhance policy planning, practice management and medical education. ..
  36. DETERMINING/UNDERSTANDING BARRIERS TO ADULT IMMUNIZATION
    Richard Zimmerman; Fiscal Year: 2000
    ..This project will furnish relevant, up-to-date to enhance policy planning, practice management and medical education. ..
  37. The Immunogenetics of Measles Immunity
    Gregory A Poland; Fiscal Year: 2010
    ..Globally, measles kills over 500,000 children annually, and small outbreaks continue to occur in the U.S. ..
  38. IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
    Gregory Poland; Fiscal Year: 2005
    ....
  39. The Immunogenetics of Measles Immunity
    Gregory Poland; Fiscal Year: 2006
    ..abstract_text> ..
  40. IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
    Gregory A Poland; Fiscal Year: 2010
    ..The knowledge gained from these studies will enable us to design new strategies and new vaccines to protect human health against viral diseases. ..
  41. The Immunogenetics of Measles Immunity
    Gregory Poland; Fiscal Year: 2005
    ..abstract_text> ..
  42. IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
    Gregory Poland; Fiscal Year: 2006
    ..The knowledge gained from these studies will enable us to design new strategies and new vaccines to protect human health against viral diseases. [unreadable] [unreadable]..
  43. NATURE OF MEASLES IMMUNITY IN TWO POPULATIONS
    Gregory Poland; Fiscal Year: 2000
    ....
  44. The Immunogenetics of Measles Immunity
    Gregory Poland; Fiscal Year: 2009
    ..Globally, measles kills over 500,000 children annually, and small outbreaks continue to occur in the U.S. ..
  45. IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
    Gregory Poland; Fiscal Year: 2009
    ..The knowledge gained from these studies will enable us to design new strategies and new vaccines to protect human health against viral diseases. ..
  46. IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
    Gregory Poland; Fiscal Year: 2008
    ..The knowledge gained from these studies will enable us to design new strategies and new vaccines to protect human health against viral diseases. ..
  47. IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
    Gregory Poland; Fiscal Year: 2007
    ..The knowledge gained from these studies will enable us to design new strategies and new vaccines to protect human health against viral diseases. [unreadable] [unreadable]..
  48. IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
    Gregory Poland; Fiscal Year: 2002
    ....
  49. The Immunogenetics of Measles Immunity
    Gregory Poland; Fiscal Year: 2002
    ..abstract_text> ..
  50. NATURE OF MEASLES IMMUNITY IN TWO POPULATIONS
    Gregory Poland; Fiscal Year: 2001
    ....
  51. IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
    Gregory Poland; Fiscal Year: 2001
    ....
  52. MEASLES IMMUNITY IN TWO POPULATIONS
    Gregory Poland; Fiscal Year: 1993
    ..These data are important in formulating national policy to eliminate measles...
  53. NATURE OF MEASLES IMMUNITY IN TWO POPULATIONS
    Gregory Poland; Fiscal Year: 1999
    ....
  54. The Immunogenetics of Measles Immunity
    Gregory Poland; Fiscal Year: 2003
    ..abstract_text> ..
  55. IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
    Gregory Poland; Fiscal Year: 2003
    ....
  56. The Immunogenetics of Measles Immunity
    Gregory Poland; Fiscal Year: 2004
    ..abstract_text> ..
  57. The Immunogenetics of Measles Immunity
    Gregory Poland; Fiscal Year: 2008
    ..Globally, measles kills over 500,000 children annually, and small outbreaks continue to occur in the U.S. ..
  58. IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
    Gregory Poland; Fiscal Year: 2004
    ....
  59. ENHANCING MUCOSAL IMMUNE RESPONSES BY MICROENCAPSULATION
    Paul Offit; Fiscal Year: 2005
    ..The availability of microencapsulated virus provides a unique opportunity to understand the relationship between APC and protective mucosal immune responses. ..
  60. VARICELLA ZOSTER VIRUS
    Anne Gershon; Fiscal Year: 2000
    ..They will investigate gene expression during putative latency, including the comparative virulence of wild type and vaccine type VZV. ..
  61. Optimal assessment of HAART adherence in routine clinical care
    Heidi M Crane; Fiscal Year: 2010
    ..Optimally and routinely assessing adherence in clinical settings is an important step toward maximizing the potential benefit of antiretroviral therapy for all patients. ..
  62. An HB Vaccine Model For HIV Vaccine Trials in Drug Users
    Lu Yu Hwang; Fiscal Year: 2007
    ..abstract_text> ..
  63. An HB Vaccine Model For HIV Vaccine Trials in Drug Users
    Lu Yu Hwang; Fiscal Year: 2005
    ..abstract_text> ..
  64. PROTECTION FROM VIRAL GASTROENTERITIS BY INTESTINAL CTLS
    Paul Offit; Fiscal Year: 1993
    ..Adaptation of murine rotaviruses to growth in tissue culture allows for an accurate determination of the virus dose used for in vitro and in vivo studies...
  65. Brucella, Aging and Role of IL-17 in Host Defense
    Kevin High; Fiscal Year: 2005
    ..The data generated in this proposal will form the foundation of future R01 proposals aimed at enhancing immunity vs. intracellular pathogens in our aging population. ..
  66. TRAINING IN PEDIATRIC INFECTIOUS DISEASE
    Anne Gershon; Fiscal Year: 2007
    ..The renewal of this training grant will enable us to continue a training program that has so far been highly successful at this University during the past 5 years. ..
  67. ENHANCING MUCOSAL IMMUNE RESPONSES BY MICROENCAPSULATION
    Paul Offit; Fiscal Year: 2001
    ..The availability of microencapsulated virus provides a unique opportunity to understand the relationship between APC and protective mucosal immune responses. ..
  68. Functional Senescence of Innate Immunity and Pneumonia
    Kevin High; Fiscal Year: 2003
    ..These data are essential to design meaningful studies using the case-control method, the most effective means of studying the link between immune senescence and infection risk. ..
  69. ENHANCING MUCOSAL IMMUNE RESPONSES BY MICROENCAPSULATION
    Paul Offit; Fiscal Year: 2003
    ..The availability of microencapsulated virus provides a unique opportunity to understand the relationship between APC and protective mucosal immune responses. ..
  70. CHEMOIMMUNOTHERAPY FOR BREAST CANCER TREATMENT
    Leisha Emens; Fiscal Year: 2006
    ..abstract_text> ..
  71. VZV Receptors and Infective Mechanisms
    Anne Gershon; Fiscal Year: 2006
    ..It may also make it possible to develop a safer and more efficacious vaccine. ..
  72. PEDIATRIC AIDS CLINICAL TRIALS UNIT
    Coleen Cunningham; Fiscal Year: 2005
    ..abstract_text> ..
  73. PEDIATRICS AIDS CLINICAL TRIALS GROUP
    Anne Gershon; Fiscal Year: 2006
    ..We have competent, outstanding staff whose aim is not only to provide compassionate medical care to HIV-infected patients but also to perform meaningful and useful research on prevention and treatment of HIV infection. ..
  74. Molecular Epidemiology, Virulence, and Genomic Characterization of Ureaplasmas
    Ken Waites; Fiscal Year: 2007
    ....
  75. ENHANCING MUCOSAL IMMUNE RESPONSES BY MICROENCAPSULATION
    Paul Offit; Fiscal Year: 2002
    ..The availability of microencapsulated virus provides a unique opportunity to understand the relationship between APC and protective mucosal immune responses. ..
  76. VZV Receptors and Infective Mechanisms
    Anne Gershon; Fiscal Year: 2007
    ..It may also make it possible to develop a safer and more efficacious vaccine. ..
  77. VZV Receptors and Infective Mechanisms
    Anne Gershon; Fiscal Year: 2005
    ..It may also make it possible to develop a safer and more efficacious vaccine. ..
  78. ENHANCEMENT OF IMMUNOGENICITY BY MICROENCAPSULATION
    Paul Offit; Fiscal Year: 1999
    ..alter the fine antigenic specificities of virus-specific neutralizing antibodies or CTLs? 4) Does oral inoculation of mice with microencapsulated virus or viral proteins enhance the capacity of immunization to protect against challenge? ..
  79. Lipodystrophy among HIV-infected patients
    Heidi Crane; Fiscal Year: 2007
    ..abstract_text> ..
  80. Dynamic Modeling of the HCV Epidemic in IDU
    Judith Hahn; Fiscal Year: 2007
    ..Public Health Relevance: This training and research will equip Dr. Hahn with the tools to conduct modeling studies based on solid epidemiologic data to guide the planning of effective interventions to reduce the HCV epidemic in IDU. ..
  81. Exploratory Center for Vaccinology Research (RMI)
    Walter Orenstein; Fiscal Year: 2007
    ..abstract_text> ..
  82. HIV Prevention and Partner Abuse: Developing an Intervention for Adolescent Girls
    Anne Teitelman; Fiscal Year: 2008
    ....
  83. VZV Receptors and Infective Mechanisms
    Anne Gershon; Fiscal Year: 2004
    ..It may also make it possible to develop a safer and more efficacious vaccine. ..
  84. VACCINE EFFICACY IN CHILDREN WITH SICKLE CELL DISEASE
    Thomas Adamkiewicz; Fiscal Year: 2006
    ..abstract_text> ..
  85. VARICELLA ZOSTER--RECEPTORS AND INFECTIVE MECHANISMS
    Anne Gershon; Fiscal Year: 1999
    ....
  86. Exploratory Center for Vaccinology Research (RMI)
    James Hughes; Fiscal Year: 2006
    ..unreadable] [unreadable]..
  87. Analyzing Vaccine Programs/Policies in Western Europe
    Gary Freed; Fiscal Year: 2004
    ..abstract_text> ..